Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311755509> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W4311755509 abstract "Abstract Background Implementation of high-quality clinical trials especially early in the pandemic caused burden on clinical investigators given lack infrastructure, networks and systematic supports. To prepare for future pandemic, we investigated facilitator and obstacles that enable investigators to operate clinical trials for COIVD-19 in Japan. Methods We conducted individual semistructured qualitative interviews to assess the process of how clinical trials for COVID-19 were planned and implemented at the early stage of pandemic. Clinical investigators were primarily selected through purposive sampling to ensure that participants involved in the clinical trials were well covered. Additional participants were identified using snowball sampling. Interviews were analyzed using qualitative descriptive method. Results Through interviews, we identify factors that can impact on conduct clinical trials in infectious diseases field during health emergency in Japan (Figure). First, there are obstacles in rolling out clinical trials and this theme was further divided into two subthemes: obstacles in system(such as lack of regulatory frameworks to support trials, lack of clinical trial networks/platform, and understanding and attitude of the public to clinical trial); and obstacles in clinical level (such as limited resource for non-academic hospitals to implement clinical trials, and lack of trained experienced researchers and coordinators with regards to clinical trials). Secondary, a few factors that facilitate clinical trials exist. Not only governmental and organizational commitment but also presence of physicians and other healthcare professional interested in conducting trials are the key for facilitate clinical trials. Facilitators and obstacles to implement clinical trials for COVID-19 therapeutics Conclusion In this qualitative study, clinical investigators in Japan who conducted clinical trials recognized both obstacles and facilitators. System level obstacles likely led to the obstacles in clinical level. Our finding emphasizes importance for health care policies to respond to such insight from front line clinical investigators to encourage systemwide efforts to facilitate and develop transparent clinical trials during future pandemic. Disclosures All Authors: No reported disclosures." @default.
- W4311755509 created "2022-12-28" @default.
- W4311755509 creator A5035397841 @default.
- W4311755509 creator A5059445557 @default.
- W4311755509 creator A5066421444 @default.
- W4311755509 creator A5082404899 @default.
- W4311755509 date "2022-12-01" @default.
- W4311755509 modified "2023-09-30" @default.
- W4311755509 title "1349. Lesson Learned from Investigators of Clinical Trials to Identify Therapeutics for COVID-19: Qualitative Study" @default.
- W4311755509 doi "https://doi.org/10.1093/ofid/ofac492.1178" @default.
- W4311755509 hasPublicationYear "2022" @default.
- W4311755509 type Work @default.
- W4311755509 citedByCount "0" @default.
- W4311755509 crossrefType "journal-article" @default.
- W4311755509 hasAuthorship W4311755509A5035397841 @default.
- W4311755509 hasAuthorship W4311755509A5059445557 @default.
- W4311755509 hasAuthorship W4311755509A5066421444 @default.
- W4311755509 hasAuthorship W4311755509A5082404899 @default.
- W4311755509 hasBestOaLocation W43117555091 @default.
- W4311755509 hasConcept C106399304 @default.
- W4311755509 hasConcept C142724271 @default.
- W4311755509 hasConcept C144024400 @default.
- W4311755509 hasConcept C15744967 @default.
- W4311755509 hasConcept C159110408 @default.
- W4311755509 hasConcept C190248442 @default.
- W4311755509 hasConcept C204787440 @default.
- W4311755509 hasConcept C2776831358 @default.
- W4311755509 hasConcept C2779134260 @default.
- W4311755509 hasConcept C3008058167 @default.
- W4311755509 hasConcept C36289849 @default.
- W4311755509 hasConcept C509550671 @default.
- W4311755509 hasConcept C512399662 @default.
- W4311755509 hasConcept C524204448 @default.
- W4311755509 hasConcept C535046627 @default.
- W4311755509 hasConcept C71924100 @default.
- W4311755509 hasConcept C77805123 @default.
- W4311755509 hasConcept C89623803 @default.
- W4311755509 hasConceptScore W4311755509C106399304 @default.
- W4311755509 hasConceptScore W4311755509C142724271 @default.
- W4311755509 hasConceptScore W4311755509C144024400 @default.
- W4311755509 hasConceptScore W4311755509C15744967 @default.
- W4311755509 hasConceptScore W4311755509C159110408 @default.
- W4311755509 hasConceptScore W4311755509C190248442 @default.
- W4311755509 hasConceptScore W4311755509C204787440 @default.
- W4311755509 hasConceptScore W4311755509C2776831358 @default.
- W4311755509 hasConceptScore W4311755509C2779134260 @default.
- W4311755509 hasConceptScore W4311755509C3008058167 @default.
- W4311755509 hasConceptScore W4311755509C36289849 @default.
- W4311755509 hasConceptScore W4311755509C509550671 @default.
- W4311755509 hasConceptScore W4311755509C512399662 @default.
- W4311755509 hasConceptScore W4311755509C524204448 @default.
- W4311755509 hasConceptScore W4311755509C535046627 @default.
- W4311755509 hasConceptScore W4311755509C71924100 @default.
- W4311755509 hasConceptScore W4311755509C77805123 @default.
- W4311755509 hasConceptScore W4311755509C89623803 @default.
- W4311755509 hasIssue "Supplement_2" @default.
- W4311755509 hasLocation W43117555091 @default.
- W4311755509 hasOpenAccess W4311755509 @default.
- W4311755509 hasPrimaryLocation W43117555091 @default.
- W4311755509 hasRelatedWork W2075155968 @default.
- W4311755509 hasRelatedWork W2114110864 @default.
- W4311755509 hasRelatedWork W2899084033 @default.
- W4311755509 hasRelatedWork W2947287702 @default.
- W4311755509 hasRelatedWork W2971584765 @default.
- W4311755509 hasRelatedWork W3197704476 @default.
- W4311755509 hasRelatedWork W4200052582 @default.
- W4311755509 hasRelatedWork W4353111288 @default.
- W4311755509 hasRelatedWork W4362613875 @default.
- W4311755509 hasRelatedWork W1585102 @default.
- W4311755509 hasVolume "9" @default.
- W4311755509 isParatext "false" @default.
- W4311755509 isRetracted "false" @default.
- W4311755509 workType "article" @default.